Charles + Colvard Ltd. buy krebskrebs
Start price
03.05.22
/
50%
€1.29
Target price
03.05.23
€1.80
Performance (%)
-33.33%
End price
04.05.23
€0.86
Summary
This prediction ended on 04.05.23 with a price of €0.86. The BUY prediction by krebskrebs for Charles + Colvard Ltd. performed very badly with a performance of -33.33%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Charles + Colvard Ltd. | - | - | - |
iShares Core DAX® | -0.116% | 1.953% | 14.155% |
iShares Nasdaq 100 | -2.733% | -1.273% | 31.828% |
iShares Nikkei 225® | -1.721% | 3.263% | 12.922% |
iShares S&P 500 | -1.527% | 0.194% | 27.117% |
Comments by krebskrebs for this prediction
In the thread Charles + Colvard Ltd. diskutieren
Buy mit Kursziel 1,8
In the thread Trading Charles + Colvard Ltd.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten